Referred to the House Committee on Foreign Affairs.
The End Tuberculosis Now Act of 2026 amends the Foreign Assistance Act to make ending tuberculosis (TB) a declared U.S. foreign assistance objective. It authorizes the President to provide bilateral and multilateral assistance focused on diagnosis, treatment, prevention, research and development, procurement, and health-system strengthening, and sets specific 2027–2030 global targets (incidence and mortality reductions, diagnostic and treatment coverage, and preventive treatment for 30 million people).
Funding: liberals seek robust appropriations; conservatives demand offsets
Relative to its intended legislative type, this bill is a substantive policy amendment to the Foreign Assistance Act that clearly defines priorities, establishes ambitious goals and detailed reporting requirements, and integrates with existing statutory authorities.
The End Tuberculosis Now Act of 2026 amends the Foreign Assistance Act to make ending tuberculosis (TB) a declared U.S. foreign assistance objective.
It authorizes the President to provide bilateral and multilateral assistance focused on diagnosis, treatment, prevention, research and development, procurement, and health-system strengthening, and sets specific 2027–2030 global targets (incidence and mortality reductions, diagnostic and treatment coverage, and preventive treatment for 30 million people).
The bill requires annual reporting to Congress, a Comptroller General evaluation within four years, coordination with partners, and sunsets the authority on January 1, 2033.
Substantive, non-controversial health authorization with clear goals, but depends on future appropriations and Senate clearance.
Relative to its intended legislative type, this bill is a substantive policy amendment to the Foreign Assistance Act that clearly defines priorities, establishes ambitious goals and detailed reporting requirements, and integrates with existing statutory authorities. It authorizes assistance and sets programmatic expectations but leaves financing and many operational implementation details to executive determination.
Funding: liberals seek robust appropriations; conservatives demand offsets
These are examples from the analysis, not a ranked list of the most-affected groups.
Funding: liberals seek robust appropriations; conservatives demand offsets
Strongly supportive.
The bill treats TB as a global public-health and equity priority, emphasizes patient-centered care, vulnerable populations, and community-led outreach.
It funds R&D, diagnostics, and integration into primary care while including robust reporting and accountability.
Generally supportive with caution.
The bill sets clear goals, monitoring, and coordination mechanisms that appeal to pragmatic oversight preferences.
Concerns focus on concrete funding, minimizing duplication, and ensuring efficient implementation in partner countries.
Cautiously mixed.
The goal of reducing TB and strengthening pandemic defenses is acceptable, but the bill raises concerns about increased foreign assistance commitments, fiscal cost, and potential federal micromanagement of international programs.
The America First language and sunset clause are modestly reassuring.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Substantive, non-controversial health authorization with clear goals, but depends on future appropriations and Senate clearance.
The bill has not accumulated any surfaced votes yet.
Funding: liberals seek robust appropriations; conservatives demand offsets
Substantive, non-controversial health authorization with clear goals, but depends on future appropriations and Senate clearance.
Relative to its intended legislative type, this bill is a substantive policy amendment to the Foreign Assistance Act that clearly defines priorities, establishes ambitious goals and detailed reporting requirements, and…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.